FDA warning letters highlight CAPA concerns
European Pharmaceutical Review
AUGUST 10, 2023
Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. Eight FDA warning letters were handed to European companies in 2018.
98 
Let's personalize your content